4See Ventures

4See Ventures is a Swiss venture capital firm established in 2019 and based in Geneva. The firm specializes in investing in exceptional entrepreneurs who are poised to redefine their industries, with a particular focus on healthcare, biotechnology, medical technology, technology, sustainability, and climate technology. By targeting game-changing ventures, 4See Ventures aims to support companies that have a positive impact on society, primarily within Switzerland.

Daniel Bertholet

Managing Partner

6 past transactions

PowerAPI

Seed Round in 2022
PowerAPI provides a white-label platform offering plug-and-play tools for corporates, agencies, and public sectors. It facilitates digitalization, enhances product offerings, meets customer needs, and enables quick market entry through OpenAPI and SDK integrations. Additionally, it serves as an all-in-one operational software for SMBs to manage their tech stack, automate operations, simplify admin tasks, grow online revenues, and accelerate business opportunities.

HAYA Therapeutics

Seed Round in 2022
HAYA Therapeutics develops RNA-based therapeutics focused on treating fibrotic diseases. Its precision medicines target specific regulators of fibrosis in tissues like the heart, aiming to block fibrosis progression and treat associated conditions safely and effectively.

CYSEC

Seed Round in 2022
CYSEC specializes in next-generation Confidential Computing solutions, securing data at rest, in motion, and in use. Their flagship product, ARCA, is a popular choice in the market.

HAYA Therapeutics

Seed Round in 2021
HAYA Therapeutics develops RNA-based therapeutics focused on treating fibrotic diseases. Its precision medicines target specific regulators of fibrosis in tissues like the heart, aiming to block fibrosis progression and treat associated conditions safely and effectively.

HAYA Therapeutics

Seed Round in 2021
HAYA Therapeutics develops RNA-based therapeutics focused on treating fibrotic diseases. Its precision medicines target specific regulators of fibrosis in tissues like the heart, aiming to block fibrosis progression and treat associated conditions safely and effectively.

keepMED

Series C in 2020
keepMED Ltd. is a medical technology company based in Rishon Le Zion, Israel, dedicated to developing innovative solutions for the treatment of Obstructive Sleep Apnea (OSA). Founded in 2012 and formerly known as Ninox Medical Ltd., the company has created keePAP, a wearable device designed to address the challenges associated with OSA. This device features a lightweight and unobtrusive nasal interface paired with a compact, battery-operated control unit, allowing for effective management of upper airway obstruction during sleep. Through its focus on disruptive technology, keepMED aims to improve the quality of life for individuals affected by this common sleep disorder.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.